Skip to main content
OpenTrials

Clinical trial condition

Acute Kidney Injury Due to Sepsis

Explore clinical trials studying Acute Kidney Injury Due to Sepsis. Study availability and eligibility vary by location and protocol.

11 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Acute Kidney Injury Due to Sepsis trial results

Recruiting

QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

NCT06517810

Conditions
Acute Kidney Injury, Acute Kidney Injury Due to Sepsis, Female Urogenital Diseases, +9 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • Lucile Packard Children's Hospital Stanford Palo Alto, California, United States
  • UCSF Benioff Children's San Francisco, California, United States
  • HealthONE HCA Rocky Mountain Children's Hospital Denver, Colorado, United States
View all 15 locations
View Trial Details
Completed

miRNA in Septic Acute Kidney Injury

NCT06498336

Conditions
Acute Kidney Injury, Acute Kidney Injury Due to Sepsis, Female Urogenital Diseases, +12 more
Locations
  • University Hospital Ostrava Ostrava, Moravian-Silesian Region, Czechia
  • University Hospital Olomouc Olomouc, Olomouc Region, Czechia
View Trial Details
Completed

Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)

NCT05996835

Conditions
Acute Kidney Injury, Acute Kidney Injury Due to Sepsis, Female Urogenital Diseases, +12 more
Locations
  • University Of Alabama Birmingham, Alabama, United States
  • UC San Francisco Medical Center San Francisco, California, United States
  • Stanford Healthcare Stanford, California, United States
  • Emory Johns Creek Hospital Johns Creek, Georgia, United States
View all 79 locations
View Trial Details
Completed

Pharmacokinetics and Safety of TIN816 in Patients With Sepsis-associated Acute Kidney Injury

NCT05507437

Conditions
Acute Kidney Injury, Acute Kidney Injury Due to Sepsis, Female Urogenital Diseases, +12 more
Locations
  • Novartis Investigative Site Genk, Belgium
  • Novartis Investigative Site Ottignies, Belgium
  • Novartis Investigative Site Strasbourg, France
  • Novartis Investigative Site Toulouse, France
View Trial Details

Related conditions